AVTX

NASDAQ · Equity

Avalo Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
15.950000
Fair value
33.500917
Expectation
Undecided 45.34%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
15.95
12-Week Change
0.95%
Trend Signal
Inactive
Expectation
Undecided 45.34%
Signal Weeks
2 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-1.11
Market Dynamics
0.57

Over the latest 12 completed weeks ending 2026-05-29, AVTX rose 0.95%, moving from 15.80 to 15.95. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -1.11 and has softened across the 12-week window. Market Dynamics is 0.57 on the latest week. Expectation is undecided at 45.34%.